Previous close | 301.60 |
Open | 303.80 |
Bid | 301.80 x 0 |
Ask | 302.60 x 0 |
Day's range | 301.20 - 304.40 |
52-week range | 250.60 - 391.90 |
Volume | |
Avg. volume | 2,899 |
Market cap | 3.896B |
Beta (5Y monthly) | 0.64 |
PE ratio (TTM) | 29.33 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.00 (0.99%) |
Ex-dividend date | 22 Apr 2024 |
1y target est | N/A |
Tecan appoints Mukta Acharya Head of the Life Sciences Business division Männedorf, Switzerland, June 24, 2024 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Mukta Acharya, currently serving as President, Tecan Americas, has been appointed the new Head of the Life Sciences Business division and a member of the Management Board of the Tecan Group. She is expected to assume her new position on August 1, 2024. Dr. Klaus Lun, Head of the Life Sciences Business since 2017 and a mem
Annual General Meeting 2024: Tecan shareholders endorse all motions proposed by the Board of Directors Increase in the dividend from CHF 2.90 to CHF 3.00 per share Monica Manotas elected as additional independent member of the Board of DirectorsLukas Braunschweiler, Myra Eskes, Oliver Fetzer, Matthias Gillner, Karen Huebscher, Christa Kreuzburg and Daniel R. Marshak re-elected as members of the Board of DirectorsLukas Braunschweiler confirmed by shareholders as Chair of the BoardMyra Eskes, Oliv
Annual General Meeting 2024: Tecan proposes election of an additional member of the Board of Directors and various amendments to the Articles of Incorporation Monica Manotas proposed as a new member of the Board of DirectorsBoard of Directors will propose all current members for re-electionVarious amendments to the Articles of Incorporation proposed to adapt them to new circumstancesReport on non-financial matters submitted for approval for the first timeProposed dividend increase from CHF 2.90